L-arginine: Rediscovery in progress

Cardiology

Volumn 90, Issue 3, 1998, Pages 153-159

  Tenenbaum, Alexander ^a   Fisman, Enrique Z ^b   Motro, Michael ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

Cardiovascular risk factors; Heart failure; Hypercholesterolemia; Ischemic heart disease; L arginine; Nitric oxide; Smoking

Indexed keywords

ARGININE; NITRIC OXIDE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CORONARY ARTERY BYPASS GRAFT; ENDOTHELIUM LESION; HEART TRANSPLANTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; PRIORITY JOURNAL; REVIEW; SMOKING;

ANIMALS; ARGININE; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RISK FACTORS;

EID: 0032447115     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006837     Document Type: Review

References (94)

1. Barbul A, Sisto DA, Wasserkrug HL, Efron G: Arginine stimulates lymphocyte immune re-sponse in healthy human beings. Surgery 1981; 90:244-251.
2. Visek WJ: Arginine: Needs, physiological state and usual diets. A reevaluation. J Nutr 1986; 116:36-46.
3. Barbul A: Arginine: Biochemistry, physiology and therapeutic implications. JPEN J Paranter Enteral Nutr 1986;10:227-238.
4. Barbul A, Rettura G, Levenson SM, Seifter E: Wound healing and hymotropic effects of arginine: A pituitary mechanism of action. Am J Clin Nutr 1983;37:786-794.
5. Greenstein JP, Wimitz M, Gullino P, Birnbaum SM, Otey MC: Prevention of ammonia toxicity by arginine and related compounds. Arch Biochem Biophys 1956;64:342-354.
6. Pegg AE, McCann PP: Polyamine metabolism and function. Am J Physiol 1982;243:C212-C221.
7. Franchimont P, Burger H: Human growth hormone and gonadotropins in health and disease. New York, Elsevier, 1975, pp 45-77.
8. Rocha DM, Faloona GR, Under RM: Glucagon-stimulating activity of 20 amino acids. J Clin Invest 1972;51:2346-2351.
9. Floid JC, Fajans SS, Conn JW, Knopf RF, Rull J: Stimulation of insulin secretion by amino acids. J Clin Invest 1966;9:1487-1502.
10. Mulloy AL, Kari FW, Visek WJ: Dietary arginine, insulin secretion, glucose tolerance and liver lipids during repletion of protein depleted rats. Horm Metab Res 1982;14:471-475.
11. De Aloysio D, Mantuano R, Mauloni M: The clinical use of arginine aspartate in male infertility. Acta Eur Fertil 1982;13:133-167.
12. Jungling ML, Bunge RD: The treatment of spermatogenic arrest with arginine. Fertil Steril 1976;27:282-283.
13. Reynolds JEF (ed): Martindale 1996, ed 31. London, Royal Pharmaceutical Society, 1996, pp 1353-1354.
14. Palmer RMJ, Ashton DS, Moncada S: Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 1988;333:664-667.
15. Snyder SH: Nitric oxide: First in a new class of neurotransmitters. Science 1992;257:494-496.
16. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-526.
17. Anggard E: Nitric oxid: Mediator, murderer, and medicine. Lancet 1994;343:1199-1206.
18. Rubanyi GM: Reversal of hypercholesterolemia-induced endothelial dysfunction by L-arginine. Circulation 1991;83:118-120.
19. Drexler H, Zeiher AM, Meinzer K, Just H: Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;338:1546-1550.
20. Creager MA, Gallagher SJ, Girerd XJ, Coleman SM, Dzau VJ, Cooke JP: L-Arginine improves endothelial-dependent vasodilation in hyper-cholesterolemic humans. J Clin Invest 1992;90:1248-1253.
21. Wang B, Singer AH, Tsao P, Drexler H, Kosek J, Cooke JP: Dietary arginine prevents atherogenesis in the coronary artery of the hyperchoolesterolemic rabbit. J Am Coll Cardiol 1994; 23:452-458.
22. Giugliano D, Marfella R, Coppola L, et al: Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Circulation 1997; 95:1783-1790.
23. Smulders RA, Stenhouwer CDA, Olthof CG, et al: Plasma endothelial levels and vascular effects of intravenous L-arginine infusion in subjects with uncomplicated insulin-dependent diabetes mellitus. Clin Sci 1994;87:37-43.
24. Furuno T, Mullen MJ, Thorne SA, et al: Intravenous L-arginine restores endothelial function in healthy young smokers (abstract). Circulation 1996;94(suppl 1):I-522.
25. Adams MR, Jessup W, Celermajer DS: Cigarette smoking is associated with increased human monocyte adhesion to endothelial cells: Reversibility with oral L-arginine but not vitamin C. J Am Coll Cardiol 1997;29:491-497.
26. Hutchison SJ, Deedwania PC, Sudhir K, et al: Environmental tobacco smoke causes endothelial dysfunction that is prevented by L-arginine in normocholesterolemic rabbits. J Am Coll Cardiol 1997;30(suppl A):387A.
27. Chauhan A, More RS, Mullins PA, Taylor G, Fetch MC, Schofield PM: Aging-associated endothelial dysfunction in humans is reversed by L-arginine. J Am Coll Cardiol 1996;28:1796-1804.
28. Boger RH, Bode-Boger SM, Brandes RP, et al: Dietary L-arginine reduces the progression of atherosclerosis in cholesterol-fed rabbits: Comparison with lovastatin. Circulation 1997;96: 1282-1290.
29. Candipan RC, Wang B, Buitrago P, Tsao PS, Cooke JP: Regression or progression: Dependency on vascular nitric oxide. Arterioscler Thromb Vasc Biol 1996;16:44-50.
30. Ross R: The pathogenesis of atherosclerosis: A perspective for the 1990's. Nature 1993;362: 801-809.
31. Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS: Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis 1997;129:261-269.
32. Rubanyi GM, Vanhoutte PM: Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am J Physiol 1986; 250:H822-H827.
33. Rubanyi GM, Vanhoutte PM: Oxygen derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol 1986; 250:H815-H821.
34. Epstein M, Sowers JR: Diabetes mellitus and hypertension. Hypertension 1992;19:403-418.
35. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Caryatte AJ, Rozels M: Pathogenesis of the atherosclerotic lesion: Implications for diabetes mellitus. Diabetes Care 1992;15:1156-1167.
36. Hsue WA, Anderson PW: Hypertension, the endothelial cell, and the vascular complications of diabetes mellitus. Hypertension 1992;20: 253-263.
37. Sowers JR, Standley PR, Ram JL, Jacober S: Hyperinsulinemia, insulin resistance, and hyperglycemia: Contributing factors in the pathogenesis of hypertension and atherosclerosis. Am J Hypertens 1993;6:260S-270S.
38. Tesfamarian B, Brown ML, Cohen RA: Elevated glucose impairs endothelium-dependent relaxation by activating protein kinase C. J Clin Invest 1991;87:1643-1648.
39. Cagliero E, Roth T, Roy S, Lorenzi M: Characteristics and mechanisms of high-glucose induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991;40:102-110.
40. Lakatta EG, Yin FCP: Myocardial aging: Functional alterations and related cellular mechanisms. Am J Physiol 1982;242:H927-H941.
41. Egashira K, Inou T, Hirooka Y, et al: Effects of age on endothelium-dependent vasodilation of resistance coronary arteries by acetylcholine in humans. Circulation 1993;88:77-81.
42. Bode-Boger SM, Boger RH, Alfke H, Heinzel D, Tsikas D, Creutzig A, Alexander K, Frolich JC: L-Arginine induces nitric oxide dependent vasodilation in patients with critical limb ischemia. Circulation 1996;93:85-90.
43. Rosano GMC, Panina G, Cerquetani E, et al: L-Arginine improves endothelial function in newly diagnosed hypertensives. J Am Coll Cardiol 1998;32(suppl A):262A.
44. Petros AJ, Hewlett HA, Bogle RG, Pearson JD: L-Arginine induced hypotension (letter). Lancet 1991;337:1044-1045.
45. Korbut R, Bieron K, Grylewski RJ: Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia (letter). N Engl J Med 1993;328:287-288.
46. Ceremuzynski L, Chamiec T, Hebraczynska-Cedro K: Effect of supplemental oral L-arginine on exercise capacity in patients with stable angina pectoris. Am J Cardiol 1997;80:331-333.
47. Quyumi AA, Dakak N, Diodati JG, Gilligan DM, Panza JA, Cannon RO III: Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J Am Coll Cardiol 1997;30:1220-1227.
48. Tousoulis D, Tentolouris D, Crake T, Katsimaglis G, Davies G, Toutouzas P: Effects of L-arginine on basal and flow-mediated nitric oxide production in atheromatous coronary arteries. J Am Coll Cardiol 1998;31(suppl A):359A.
49. Bellamy MF, Goodfellow J, Tweddel AC, et al: Oral L-arginine improves exercide tolerance and flow-related endothelial dysfunction in microvascular angina (abstract). Circulation 1996;94(suppl 1):I-425.
50. Weyrich AS, Ma X-L, Lefer AM: The role of L-arginine in ameliorating reperfusion injury after myocardial ischemia in the cat. Circulation 1992;86:279-288.
51. Lou H, Kodama T, Wang YN, Katz N, Ramwell P, Foegh ML: L-Arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-1 and interleukin-6. J Heart Lung Transplant 1996;15:1248-1257.
52. Lubec B, Hayn M, Kitzmuller E, Vierhapper H, Lubec L: L-Arginine reduces lipid peroxidation in patients with diabetes mellitus. Free Radic Biol Med 1997;22:355-357.
53. Koifman B, Wollman Y, Bogomolny N, et al: Improvement of cardiac performance by intravenous infusion of L-arginine in patients with moderate congestive heart failure. J Am Coll Cardiol 1995;26:1251-1261.
54. Rector TS, Bauk AJ, Muller KA, et al: Randomized, double-blind, placebo-controlled study of supplemental oral L-arginine in patients with heart failure. Circulation 1996;93: 2135-2141.
55. Chin-Dusting JPF, Kaye CM, Lefkovits J, Wong J, Bergin P, Jennings GL: Dietary supplementation with L-arginine fails to restore endothelial function in forearm resistance arteries of patients with severe heart failure. J Am Coll Cardiol 1996;27:1207-1213.
56. Tsao PS, Theilmeier G, Singer AH, Leung LK, Cooke JP: L-Arginine attenuates platelet reactivity in hypercholesterolemic rabbits. Arterioscler Thromb 1994;14:1529-1533.
57. Wolf A, Zalpour C, Theilmeier G, Wang B-Y, MaA, Anderson B, Tsao PS, Cooke JP: Dietary L-arginine supplementation normalizes platelet aggregation in hypercholesterolemic humans. J Am Coll Cardiol 1997;29:479-485.
58. Wang BY, Candiran RC, Arjomandi M, Hsiun PTC, Tsao PS, Cooke JP: Arginine restores nitric oxide activity and inhibits monocyte accumulation after vascular injury in hypercholesterolemic rabbits. J Am Coll Cardiol 1996;28: 1573-1579.
59. Schwarzacher S, Lim TT, Wang B, et al: Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 1997;95:1863-1869.
60. McNamara DM, Bodi B, Aurora H, et al: L-Arginine inhibits balloon catheter induced intimal hyperplasia. Biochem Biophys Res Commun 1993;193:291-296.
61. Hamon M, Vallet B, Bauters B, et al: Long-term oral administration of L-arginine reduces intimai thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury. Circulation 1994;90: 1357-1362.
62. Tarry WC, Makhoul RG: L-Arginine improves endothelium dependent vasorelaxation and reduces intimai hyperplasia after balloon angioplasty. Arterioscler Thromb Vasc Biol 1994;14: 938-943.
63. Drexler H, Fischell TA, Pinto FJ, et al: Effect of L-arginine on coronary endothelial function in cardiac transplant recipients: Relation to vessel wall morphology. Circulation 1994;89:1615-1623.
64. Shiono N, Cohen G, Weisel RD, et al: L-Arginine protects human ventriculae cardiomyocytes from ischemic injury (abstract). Circulation 1996;94(suppl 1):I-414.
65. Amrani M, Gray C, Goodwin A, Smolenski RT, Marchban KA, Yacoub MH: Effects of L-arginine in cardioplegia and during reperfusion after prolonged cardioplegic arrest (abstract). Circulation 1996;94(suppl 1):I-115.
66. Rossitch E Jr, Alexander E III, Black P, Cooke JP: L-Arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbit. J Clin Invest 1991;87:1295-1299.
67. Scull CW, Rose WC: Arginine metabolism. J Biol Chem 1930;89:109-123.
68. Morris JG: Nutritional and metabolic responses to arginine deficiency in carnivores. J Nutr 1985;115:524-531.
69. Deshmukh D, Shope TC: Arginine requirement and ammonia toxicity in ferrets. J Nutr 1983;113:1664-1667.
70. Czarnecki GL, Baker DH: Urea cycle function in the dog with emphasis on the role of arginine. J Nutr 1984;114:581-590.
71. Bode-Boger SM, Boger RH, Kienke S, Junker W, Frolich JC: Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 1996;219:598-603.
72. Nagase S, Takemura K, Ueda A, et al: A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem Biophys Res Commun 1997;233:150-153.
73. Chowienczyk P, Ritter J: Arginine: NO more than a simple amino acid (letter)? Lancet 1997; 350:901.
74. Aji W, Ravalli S, Szabolcs M, et al: L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation 1997;95:430-437.
75. Cooke JP, Tsao PS: Arginine: A new therapy for atherosclerosis? Circulation 1997;95:311-312.
76. Malczewska-Malec M, Goldsztajn P, Kawecka-Jaszcz K, et al: Effects of prolonged L-arginine administration on blood-pressure in patients with essential hypertension. Agents Actions Suppl 1995;45:157-162.
77. Sun Y-P, Zhu B-Q, Browne AEM, et al: L-Arginine decreases blood pressure and left ventricular hypertrophy in rats with experimental aortic coarctation. J Am Coll Cardiol 1998; 31(suppl A):501A.
78. Surdacki A, Zmudka K, Bieron K, Kostka-Trabka E, Dubiel JS, Gryglewski RJ: Lack of beneficial effects of L-arginine infusion in primary pulmonary hypertension. Wien Klin Wochenschr 1994;106:521-526.
79. Cheng D, Chen W, Yang X: Protective and treated effects of L-arginine on hypoxia-induced pulmonary hypertension in rats. Hua Hsi I Ko Ta Hsueh Hsueh Pao 1996;27:68-70.
80. Smith SD, Wheeler MA, Foster HE Jr, Weiss RM: Improvement in interstitial cystitis symptom scores during treatment with oral L-arginine. J Urol 1997;158:703-708.
81. Burnett AL, Lowenstein CJ, Bredt DS, et al: Nitric oxide: A physiological mediator of penile erection. Science 1992;257:401-403.
82. Peters H, Noble NA: Dietary L-arginine in renal disease. Semin Nephrol 1996;16:567-575.
83. Senkal M, Mumme A, Eickoff U, et al: Early postoperative enterai immunonutrition: Clinical outcome and cost-comparison analysis in surgical patients. Crit Care Med 1997;25: 1489-1496.
84. Brittenden J, Heys SD, Miller I, et al: Dietary supplementation with L-arginine in patients with breast cancer (>4 cm) receiving multimodality treatment: Report of a feasibility study. Br J Cancer 1994;69:918-921.
85. Kemen M, Senkal M, Homann HH, et al: Early postoperative enterai nutrition with arginine, omega-3 fatty acids and ribonucleic acid supplemented diet versus placebo in cancer patients: An immunologic evaluation and impact. Crit Care Med 1995;23:652-659.
86. Adawi D, Kasravi FB, Molin G, Jeppson B: Oral arginine supplementation in acute liver injury. Nutrition 1996;12:529-533.
87. Dewitt DS, Smith TG, Deyo DJ, Miller KR, Uchida T, Prough DS: L-Arginine and superoxide dismutase prevent or reverse cerebral hypoperfusion after fluid-percussion traumatic brain injury. J Neurotrauma 1997;14:223-233.
88. Bushinsky DA, Gennary FJ: Life-threatening hyperkalemia induced by arginine. Ann Intern Med 1978;89:632-634.
89. Wascher T, Bahadozi B, Habersack-Wallner SH, Toplak H: Oral L-arginine supplementation in chronic heart failure (letter). Circulation 1997;95:1674-1675.
90. Chigo E, Ceda GP, Valcavi R, et al: Low doses of either intravenously or orally administered arginine are able to enhance growth hormone releasing hormone in elderly subjects. J Endocrinol Invest 1994;17:113-117.
91. Boger RH, Shellong SM, Bode-Boger SM, Galland A, Burchert W, Frolich JC: L-Arginine increases nutritive muscular blood flow determined by positron emission tomography (PET) in patients with peripheral arterial occlusive disease (abstract). Circulation 1996;94(suppl 1):I-543.
92. Boulanger H, Berkane N, Pruna A: Role of nitric oxid in pregnancy and preeclampsia. Nephrologic 1997;18:81-90.
93. Facchinetti F, Neri I, Genazzani AR: L-Arginine infusion reduces preterm uterine contractions. J Perinat Med 1996;24:283-285.
94. Bellone J, Bartolotta E, Cardinale G, Arvat E, Cherubini V, Aimaretti G, Maccario M, Mucci M, Camanni F, Chigo E: Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children. J Endocrinol Invest 1993;16: 521-525.